BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Talbot CJ, Veldwijk MR, Azria D, Batini C, Bierbaum M, Brengues M, Chang-Claude J, Johnson K, Keller A, Smith S, Sperk E, Symonds RP, Wenz F, West CML, Herskind C, Bourgier C. Multi-centre technical evaluation of the radiation-induced lymphocyte apoptosis assay as a predictive test for radiotherapy toxicity. Clin Transl Radiat Oncol 2019;18:1-8. [PMID: 31341970 DOI: 10.1016/j.ctro.2019.06.001] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
Number Citing Articles
1 Drobin K, Marczyk M, Halle M, Danielsson D, Papiez A, Sangsuwan T, Bendes A, Hong MG, Qundos U, Harms-Ringdahl M, Wersäll P, Polanska J, Schwenk JM, Haghdoost S. Molecular Profiling for Predictors of Radiosensitivity in Patients with Breast or Head-and-Neck Cancer. Cancers (Basel) 2020;12:E753. [PMID: 32235817 DOI: 10.3390/cancers12030753] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
2 Chaouni S, Lecomte DD, Stefan D, Leduc A, Barraux V, Leconte A, Grellard JM, Habrand JL, Guillamin M, Sichel F, Laurent C. The Possibility of Using Genotoxicity, Oxidative Stress and Inflammation Blood Biomarkers to Predict the Occurrence of Late Cutaneous Side Effects after Radiotherapy. Antioxidants (Basel) 2020;9:E220. [PMID: 32156042 DOI: 10.3390/antiox9030220] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
3 Lapierre A, Bourillon L, Larroque M, Gouveia T, Bourgier C, Ozsahin M, Pèlegrin A, Azria D, Brengues M. Improving Patients’ Life Quality after Radiotherapy Treatment by Predicting Late Toxicities. Cancers 2022;14:2097. [DOI: 10.3390/cancers14092097] [Reference Citation Analysis]
4 Thomas A, Keller A, Menoux I, Brahimi Y, Vigneron C, Le Fèvre C, Chambrelant I, Pietta G, Guihard S, Clavier J, Antoni D, Noël G. Étude des facteurs pronostiques de radiodermite aiguë dans le cancer du sein traité par irradiation conformationnelle adjuvante avec ou sans modulation d’intensité. Cancer/Radiothérapie 2022. [DOI: 10.1016/j.canrad.2021.12.004] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
5 Moquet J, Rothkamm K, Barnard S, Ainsbury E. Radiation Biomarkers in Large Scale Human Health Effects Studies. J Pers Med 2020;10:E155. [PMID: 33023046 DOI: 10.3390/jpm10040155] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
6 Li R, Wang H, Liang Q, Chen L, Ren J. Radiotherapy for glioblastoma: clinical issues and nanotechnology strategies. Biomater Sci 2022. [PMID: 34989724 DOI: 10.1039/d1bm01401c] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]